What is the Fiscal Year for Neuphoria Therapeutics?
Date: November 13, 2026
Neuphoria Therapeutics's current fiscal year starts on July 1, 2026, and ends on June 30, 2027. Their current quarter is Q2, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
July 1, 2026
Fiscal Year End
June 30, 2027
Current Quarter
Q2
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jul 1, 2026 – Sep 30, 2026
Q2
Oct 1, 2026 – Dec 31, 2026
Q3
Jan 1, 2027 – Mar 31, 2027
Q4
Apr 1, 2027 – Jun 30, 2027
Company Information
Headquarters
Burlington, Massachusetts
Industry
Biotechnology Research
Stock Symbol
NEUP
Website
http://www.neuphoriatx.comDescription
At Neuphoria Therapeutics, we are dedicated to pioneering breakthrough therapies that address the complex needs of individuals affected by neuropsychiatric disorders. By focusing on novel approaches and advancing scientific understanding, we aim to deliver medicines that offer lasting relief and hope for a brighter, healthier future. To learn more about the company, pipeline and collaboration opportunities, visit us at www.neuphoriatx.com
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Neuphoria Therapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.